Literature DB >> 15145092

From knowledge to practice in chronic cardiovascular disease: a long and winding road.

Sumit R Majumdar1, Finlay A McAlister, Curt D Furberg.   

Abstract

Although clinical practices evolve over time, the translation of specific research evidence into clinical practice is unpredictable, inconsistent, and complex. In this paper, we use examples from chronic cardiovascular conditions to: 1). highlight two types of care gaps; 2). describe the most common potential barriers to the application of evidence into clinical care; and 3). outline which of the strategies for translating evidence into clinical care have been shown to be ineffective, which strategies have been shown to be effective and to describe some untested approaches that hold promise.

Entities:  

Mesh:

Year:  2004        PMID: 15145092     DOI: 10.1016/j.jacc.2003.12.043

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  49 in total

1.  Distributed guidelines (DiG): a software framework for extending automated health decision support to the general population.

Authors:  Edwin Yaqub; Andre Barroso
Journal:  Perspect Health Inf Manag       Date:  2010-09-01

2.  The Canadian Hypertension Education Program--a unique Canadian initiative.

Authors:  F A McAlister
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

3.  The Canadian Hypertension Education Program (CHEP) recommendations: launching a new series.

Authors:  Finlay A McAlister; Eric Wooltorton; Norman R C Campbell
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

Review 4.  Primary care practice-based research networks: working at the interface between research and quality improvement.

Authors:  James W Mold; Kevin A Peterson
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

5.  Building safer systems by ecological design: using restoration science to develop a medication safety intervention.

Authors:  P B Marck; J A Kwan; B Preville; M Reynes; W Morgan-Eckley; R Versluys; L Chivers; B O'Brien; J Van der Zalm; M Swankhuizen; S R Majumdar
Journal:  Qual Saf Health Care       Date:  2006-04

6.  Missed opportunities for the secondary prevention of cardiovascular disease in Canada.

Authors:  Daniel G Hackam; Lawrence A Leiter; Andrew T Yan; Raymond T Yan; Aurora Mendelsohn; Mary Tan; Louis Zavodni; Richard Chen; Jennifer L Tsang; Anjali Kundi; Peter J Lin; David H Fitchett; Anatoly Langer; Shaun G Goodman
Journal:  Can J Cardiol       Date:  2007-12       Impact factor: 5.223

Review 7.  An overview of practice facilitation programs in Canada: current perspectives and future directions.

Authors:  Clare Liddy; Dianne Laferriere; Bruce Baskerville; Simone Dahrouge; Lyndee Knox; William Hogg
Journal:  Healthc Policy       Date:  2013-02

8.  Epidemiology of cardioprotective pharmacological agent use in stable coronary heart disease.

Authors:  Krishna Kumar Sharma; Mukul Mathur; Rakesh Gupta; Soneil Guptha; Sanjeeb Roy; R S Khedar; Nishant Gupta; Rajeev Gupta
Journal:  Indian Heart J       Date:  2013-04-09

Review 9.  Defining knowledge translation.

Authors:  Sharon E Straus; Jacqueline Tetroe; Ian Graham
Journal:  CMAJ       Date:  2009-07-20       Impact factor: 8.262

10.  Improving evidence based cardiac care and policy implementation over the patient journey: the potential of coronary heart disease registers.

Authors:  A M Clark; I N Findlay
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.